A 63-year-old man with a history of ischaemic heart disease was admitted with an increased rate of firing of his implantable cardioverter defibrillator (ICD). The ICD was inserted four years previously to control episodes of ventricular tachycardia (VT) following an anterior myocardial infarction 11 years earlier. Over a two-hour period, the ICD was firing approximately six times every 10 minutes in response to VT; this fulfils the criteria for the diagnosis of electrical storm. Underlying electrolyte abnormalities (admission serum potassium was measured at 3.3 mmol/L and magnesium 0.60 mmol/L) were treated and intravenous atenolol (10 mg) and amiodarone were given. Unfortunately, no reduction in ICD firing occurred. Interrogation of the ICD showed that it was working correctly, appropriately defibrillating in response to VT. Sedation with midazolam (10 mg) to reduce catecholamine drive had been attempted but was unsuccessful.
The cardiology team referred the patient to critical care with a view to anaesthesia and mechanical ventilation as a means of reducing intrinsic catecholamine release thought to be sustaining the electrical storm. They were aware of a case report describing this as a technique of 'last resort. ' On the critical care unit, a central venous catheter was inserted to allow more rapid correction of hypokalaemia after repeat blood testing still demonstrated a suboptimal serum potassium level (3.4 mmol/L). A low-dose propofol infusion (20-60 mg/hr) was started following review of a previous case report showing a possible electrical storm suppressing effect of propofol. 1 This rapidly resulted in cessation of ICD activity with no further episodes of VT. The patient was lightly sedated throughout. Propofol was continued for a further 12 hours. Following multidisciplinary discussion, regular oral diazepam (2 mg three times a day) and oral clonidine (150 µg hourly) were started. Electrical stability ensued, and 12 hours later the patient was transferred back to coronary care for ongoing management and possible catheter ablation.
Discussion
As stated above, electrical storm is defined as three or more separate episodes of VT or ventricular fibrillation in a 24-hour period. 2 Electrical storm is described solely in the post ICD era, as prior to this most patients with electrical storm would have died. Death resulted from cardiac failure due to global myocardial ischaemia resulting from the repeated ventricular arrythmias.
Even with the presence of an ICD, electrical storm is associated with increased mortality. A study of 169 consecutive patients fitted with ICDs found that 32 patients (19%) had at least one episode of electrical storm during follow up. 3 Patients with electrical storm were older (mean age 64 vs 59 years) and had more advanced congestive heart failure (mean New York Heart Association Classification of Heart Failure score 2.4 vs 2.1) than those who did not suffer from electrical storm. Electrical storm was an independent predictor of cardiac death with a relative risk ratio of 2.59. However, in a smaller study with a shorter follow-up period, no difference in mortality could be detected in patients with and without electrical storm. 4 Another review with small patient numbers failed to show a causal association. 5 The mainstay of treatment is reducing sympathetic tone with beta blockers and if necessary benzodiazepines for anxiolysis. Amiodarone has been successfully used. 2 A newer class III agent, azilimide, has been used successfully in the SHEILD study in preventing electrical storm and may yet prove useful in acute management. 6 Treatment of electrolyte imbalances with potassium and magnesium is essential. 2 Catheter ablation is used only in severe refractory cases. 2 A single case report demonstrating cessation of VT with propofol has also been published, although this was used in combination with multiple anti-arrhythmic drugs. 1 General measures including ACE inhibitors and statins can be further used to reduce the risk of arrhythmias in the future following an episode of electrical storm. 2
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In critical care, situations may occur where optimal treatment is unknown. Advances in patient management in other specialties can impact on referrals for our expertise in physiological and pharmacological support. A 63-year-old man required sedation and monitoring in critical care to suppress endogenous catecholamine release for treatment of an electrical storm (defined as three or more episodes of ventricular tachycardia or fibrillation within 24 hours). This case report illustrates the importance of multi-disciplinary input when novel techniques are employed.
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Case reports
While we were unable to find any reports of the therapeutic use of clonidine in these circumstances, we felt that it was appropriate to try it because of its theoretical pharmacodynamic benefits. Clonidine acts by stimulating presynaptic alpha-2 receptors. 7 This decreases noradrenaline release from the sympathetic nerve terminals thereby reducing sympathetic tone. Although it decreases blood pressure, it has no effect on cardiac contractility and, consequently, cardiac output is maintained. 7 Clonidine may cause bradycardia as well as its sedative and anxiolytic actions. 7 Oral administration also makes it suitable as part of a medium-term treatment strategy.
Clonidine was used in our patient only following extensive discussion between cardiology and critical care teams, as it is a novel treatment for this condition. Any potentially deleterious side effects such as hypotension and bradycardia would be easy to manage in the critical care setting.
Conclusion
This case report illustrates the importance of a good multidisciplinary approach to an unusual clinical problem which does not usually require critical care intervention. Clonidine appears to be effective as an adjunct to maintaining electrical stability in patients who have recently suffered from electrical storm. important treatment modality for patients with life threatening ventricular arrhythmias. Reports suggest that 10 to 20% patients will experience electrical storms within three years of implantation as the pathological processes within the conducting systems advance. 1, 2 One consideration when describing new indications for admission to critical care is an increase in pressure on fixed capacity. Equity of access to critical care for deserving patients is a fundamental pillar of critical care' s admission policies. New patient streams are inevitable with advances in critical care and in medicine.
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Sedation or general anaesthesia on ICU is certainly an option but Dr Porter' s report does not conclusively prove whether or not clonidine had a direct effect. Before initiating critical care support, what other options might be open to terminate the electrical storm and so avert a critical care admission? Removing the triggering factors such as relieving myocardial ischaemia, treating infection especially if associated with pyrexia, correcting hypo or hyperkalaemia, treating hypothyroidism and acute heart failure should be undertaken concurrently. As Dr Porter reports amiodarone is the treatment of choice and if resistant a beta blocker can be added. Intravenous metopralol has been used in the acute setting. 3 Newer drugs reported to be effective include azimilide (Class III antiarhhythmic that acts by blocking calcium channels so prolongs action potentials and the refractory periods) 4 and landiolol (an ultra-short-acting beta one selective blocker). 5 Unfortunately these two drugs are not listed in the BNF.
Esmolol has been used to terminate electrical storms. 6 Dr Porter' s case report is useful as it highlights an unusual request for critical care. However with the constrained UK critical care capacity, it is probably important that other treatment modalities mentioned above have been tried and proved ineffective.
